NCT06486688 Centralized Virtual SBIRT for Pediatric Primary Care
| NCT ID | NCT06486688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaiser Permanente |
| Condition | Adolescent Alcohol Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 22,320 participants |
| Start Date | 2024-02-13 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22,320 participants in total. It began in 2024-02-13 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adolescent alcohol and other drug (AOD) use is a significant public health problem which contributes to high levels of mortality, morbidity and healthcare costs in young people, and identification and early intervention for these problems is critical to improving outcomes. Screening, Brief Intervention and Referral to Treatment (SBIRT) in pediatric primary care is an evidence-based strategy for addressing these problems, but has not been widely and systematically implemented, for a variety of reasons, including lack of training and staffing resources to support its implementation. This pragmatic, Type 1 Hybrid Comparative Effectiveness Implementation study will examine whether a centralized, virtually-delivered modality of SBIRT, rapidly accessible by multiple pediatric primary care clinics, can be cost-effectively implemented to improve early identification and treatment for AOD use and comorbid mental health problems among adolescents identified as being at high or severe risk of AOD use disorder during adolescent Well Visits.
Eligibility Criteria
Inclusion Criteria: • The sample will include all adolescents aged 12 through 17 years seen for a Well Visit, who are at risk of AOD use disorder defined as endorsing monthly or more frequent AOD use OR any AOD use and past-two-week depressive symptoms or suicidality. Exclusion Criteria: • N/A - all adolescents with a Well Visit are eligible
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06486688 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Adolescent Alcohol Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06486688 currently recruiting?
Yes, NCT06486688 is actively recruiting participants. Contact the research team at Stacy.A.Sterling@kp.org for enrollment information.
Where is the NCT06486688 trial being conducted?
This trial is being conducted at Pleasanton, United States.
Who is sponsoring the NCT06486688 clinical trial?
NCT06486688 is sponsored by Kaiser Permanente. The trial plans to enroll 22,320 participants.